Download PDF
Thromb Haemost 1990; 64(04): 569-575
DOI: 10.1055/s-0038-1647360
Original Article
Schattauer GmbH Stuttgart

A Comparative Study of Three Methods for the Visualization of von Willebrand Factor (vWF) Multimers

M R Ledford
The Department of Pathology, the University of Miami School of Medicine, Miami, Florida, U.S.A.
,
J W Kent
The Department of Pathology, the University of Miami School of Medicine, Miami, Florida, U.S.A.
,
F Civantos
The Department of Pathology, the University of Miami School of Medicine, Miami, Florida, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 02 January 1990

Accepted after revision13 July 1990

Publication Date:
25 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

This study was performed to compare three visualization methods for the detection of vWF multimers: autoradiography (125I), electroblot with a horseradish peroxidase system (BLOT-HRP), and an avidin-biotin peroxidase system (AV-BIO). Each method was evaluated according to: 1) ability to visually detect bands and subbands thereby identifying von Willebrand’s disease (vWD) subtypes and normals, 2) reagent availability, 3) cost, and 4) time requirements. Additionally, resolvability was evaluated utilizing low, intermediate, and high resolution gels prepared with both low and high gelling temperature agaroses with subsequent visualization by the three detecting systems.

With intermediate resolution gels, our results showed that all three visualization methods could discern pathologic patterns from normal. In addition, the avidin-biotin peroxidase system demonstrated the best band discreteness with low resolution gels used to detect unusually high molecular weight multimers. With high resolution gels used for subtyping type II vWD, we found the internal band structure was best demonstrated using LGT agarose and the electroblot horseradish peroxidase system.

 

  • References

  • 1 Ruggeri ZM, Zimmerman TS. Variant von Willebrand’s disease. Characterization of two subtypes by analysis of multimeric composition of factor VUI/von Willebrand factor in plasma and platelets. J Clin Invest 1980; 65: 1318-1325
    CrossrefPubMedGoogle Scholar
  • 2 Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VUI/von Willebrand factor. Blood 1981; 57: 1140-1143
    PubMedGoogle Scholar
  • 3 Hoyer LW, Shainoff JR. Factor VIII related protein circulates in normal human plasma as high molecular weight multimers. Blood 1980; 55: 1056-1059
    PubMedGoogle Scholar
  • 4 Enayat MS, Hill FG H. Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 1983; 36: 915-919
    CrossrefPubMedGoogle Scholar
  • 5 Furlong BL, Peake IR. An electroblotting technique for the detection of factor VUI/von Willebrand factor multimers in plasma. Br J Haematol 1983; 53: 641-653
    CrossrefPubMedGoogle Scholar
  • 6 Miller MA, Palascak JE, Thompson MR, Martelo OJ. A modified SDS agarose gel method for determining factor VIII von Willebrand multimers using commercially available reagents. Thromb Res 1985; 39: 777-780
    CrossrefPubMedGoogle Scholar
  • 7 Bukh A, Ingerslev J, Stenberg S, Hundahl Moller NP. The multimeric structure of plasma FVIII :RAg studied by electroelution and immunoperoxidase detection. Thromb Res 1986; 43: 579-584
    CrossrefPubMedGoogle Scholar
  • 8 Lombardi R, Gelfi C, Righetti PG, Lattuada A, Mannucci PM. Electroblot and immunoperoxidase staining for rapid screening of the abnormalities of the multimeric structure of von Willebrand factor in von Willebrand’s disease. Thromb Haemostas 1986; 55: 246-249
    PubMedGoogle Scholar
  • 9 Zaleski A, Henriksen RA. Visualization of the multimeric structure of von Willebrand factor using a peroxidase-conjugated second antibody. J Lab Clin Med 1986; 107: 172-175
    PubMedGoogle Scholar
  • 10 Brosstad F, Kjonniksen I, Ronning B, Stormorken H. Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies. Thromb Haemostas 1986; 55: 276-278
    PubMedGoogle Scholar
  • 11 Aihara M, Sawada Y, Ueno K, Morimoto S, Yoshida Y, de Serres M, Cooper HA, Wagner RH. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex. Thromb Haemostas 1986; 55: 263-267
    PubMedGoogle Scholar
  • 12 Dalton RG, Lasham A, Savidge GF. A new rapid semi-dry blotting technique for multitimeric sizing of von Willebrand factor. Thromb Res 1988; 50: 345-349
    CrossrefPubMedGoogle Scholar
  • 13 Schneppenheim R, Plendl H, Budde U. Luminography - an alternative assay for detection of von Willebrand factor multimers. Thromb Haemostas 1988; 60: 133-136
    PubMedGoogle Scholar
  • 14 Farias C, Kempfer AC, Blanco A, Woods A, Lazzari MA. Visualization of the multimeric structure of von Willebrand factor by immunoenzymatic stain using avidin-peroxidase complex instead of avidin-biotin peroxidase complex. Thromb Res 1989; 53: 513-518
    CrossrefPubMedGoogle Scholar
  • 15 Tomita Y, Harrison J, Abildgaard C. von Willebrand factor multimer analysis using a sensitive peroxidase staining method. Thromb Haemostas 1989; 62: 781-783
    PubMedGoogle Scholar
  • 16 Mannucci PM, Abildgaard CF, Gralnick HR, Hill FG H, Hoyer LW, Lombardi R, Nilsson IM, Tuddenham E, Meyer D. Multicenter comparison of von Willebrand factor multimer sizing techniques. Report of the factor VIII and von Willebrand factor subcommittee. Thromb Haemostas 1985; 54: 873-877
    PubMedGoogle Scholar
  • 17 National Committee for Clinical Laboratory Standards. NCCLS Publication: H21-T, Tentative guidelines for the standardized collection, transport and preparation of blood specimens for coagulation testing and performance of coagulation assays. NCCLS, Villanova 1981; 2: 104-128
    PubMedGoogle Scholar
  • 18 Mannucci PM, Lombardi R, Federici AB, Dent JA, Zimmerman TS, Ruggeri ZM. A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF). Blood 1986; 68: 269-274
    CrossrefPubMedGoogle Scholar
  • 19 Gralnick HR, Williams SB, McKeown LP, Krizek DM, Shafer BC, Rick ME. Platelet von Willebrand factor: comparison with plasma von Willebrand factor. Thromb Res 1985; 38: 623-633
    CrossrefPubMedGoogle Scholar
  • 20 Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S, Mazzucconi MG, Mariani G. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 1985; 66: 796-802
    PubMedGoogle Scholar
  • 21 Nochumson S, Cook RB, Williams KW. A new, extremely low gelling temperature agarose and its applications. Presentation at Electrophoresis Forum ‘80 1980
    PubMedGoogle Scholar
  • 22 Pezzetti L, Radaelli R, Caimi TM, Cattaneo D, Baudo F, de Cataldo F. Demonstration of a multimeric pattern in severe von Willebrand’s disease plasma. Thromb Haemostas 1989; 62: 220 (Abstr)
    PubMedGoogle Scholar
  • 23 Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS. Multimeric composition of factor VIH/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand’s disease subtypes. Blood 1982; 59: 1272-1278
    PubMedGoogle Scholar
  • 24 Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-1435
    CrossrefPubMedGoogle Scholar
  • 25 Mannucci PM, Lombardi R, Lattuada A, Ruggenenti P, Vigano GL, Barbui T, Remuzzi G. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Blood 1989; 74: 978-983
    PubMedGoogle Scholar
  • 26 Zimmerman TS, Dent JA, Federici AB, Ruggeri ZM, Nilsson IM, Holmberg L, Abildgaard CF, Nannini LH. High resolution Na Dod So4-agarose electrophoresis identifies new molecular abnormalities in von Willebrand disease. Clin Res 1984; 32 A 501
    PubMedGoogle Scholar
  • 27 Kinoshita S, Harrison J, Lazerson J, Abildgaard CF. A new variant of dominant type II von Willebrand’s disease with aberrant multimeric pattern of factor VUI-related antigen (type II D). Blood 1984; 63: 1369-1371
    PubMedGoogle Scholar
  • 28 Gershoni JM, Palade GE. Protein blotting: principles and applications. Anal Biochem 1983; 131: 1-15
    CrossrefPubMedGoogle Scholar
  • 29 Pluskal MG, Przekop MB, Kavonian MR, Vecoli C, Hicks DA. ImmobilonTM PVDF transfer membrane: a new membrane substrate for western blotting of proteins. Biotechniques 1986; 4: 272-282
    PubMedGoogle Scholar